Impact of postoperative integrated genomic and epigenomic signatures of circulating tumor DNA (ctDNA) on recurrence in resected colorectal cancer: Initial report of a prospective ctDNA monitoring study COSMOS-CRC-01.

Authors

null

Yuichiro Tsukada

Department of Colorectal Surgery, National Cancer Center Hospital East, Kashiwa, Japan

Yuichiro Tsukada , Nobuhisa Matsuhashi , Tatsuro Murano , Manabu Shiozawa , Takeshi Kato , Eiji Oki , Masahiro Goto , Yoshinori Kagawa , Akiyoshi Kanazawa , Takashi Ohta , Akira Ouchi , Hideaki Bando , Xiaotong Zuo , Princy Parsana , Kristin Sedgwick Price , Hiroaki Ikematsu , Takayuki Yoshino , Yoshiaki Nakamura

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

UMIN000037765

DOI

10.1200/JCO.2022.40.4_suppl.168

Abstract #

168

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2014 ASCO Annual Meeting

Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).

Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).

First Author: Jeanne Tie

First Author: Qingqi Hong

First Author: Xiaoru Tian